Area of research
Psychiatry and Mental health · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Attention Deficit Hyperactivity Disorder, Diabetes Treatment and Management, Maternal Mental Health During Pregnancy and Postpartum, and Pharmacovigilance and Adverse Drug Reactions.
Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study
Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes
Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother–child pairs
Sex-specific comparative outcomes between oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
Association between prenatal antipsychotic exposure and the risk of attention-deficit/hyperactivity disorder and autism spectrum disorder: a systematic review and meta-analysis
Abstract 4118762: Large-scale multinational trends in the use of cardioprotective antihyperglycemic agents as first-line therapy in patients with type 2 diabetes and cardiovascular disease: a LEGEND-T2DM study
Changes in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study
Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study
ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases
Prenatal and Infant Exposure to Acid-Suppressive Medications and Risk of Allergic Diseases in Children
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM
Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age
Global epidemiology of hip fractures: a study protocol using a common analytical platform among multiple countries
Cardiovascular and metabolic risk of antipsychotics in children and young adults: a multinational self-controlled case series study
Using propensity scores to estimate effects of treatment initiation decisions: State of the science
Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study
Antipsychotic drug use in pregnancy: A multinational study from ten countries
Application of Healthcare ‘Big Data’ in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN)
Trazodone use and risk of dementia: A population-based cohort study
Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK
Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases
Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study
Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: A systematic review and meta-analysis
Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: A systematic review and meta-analysis of observational studies
Methylphenidate and the Risk of Trauma